药典标准品是指由国家药品监督管理局认定并公布的、用于药物质量控制的标准物质,其纯度、含量及稳定性等特性已经过严格验证。药典标准品在确保药品质量和安全性方面起着至关重要的作用。
杂质标准品则是指用于检测药物中可能存在的各种类型杂质的化学试剂或混合物。与药典标准品不同的是,杂质标准品不一定是单一化合物的标准品,它们可以是特定类型的杂质或是代表性的杂质混合物,旨在帮助制药企业进行质量控制和开发更为严格的生产工艺。
两者在药品生产和监管中都发挥着重要作用:药典标准品用于检测药物的主要成分是否符合规定的含量范围;而杂质标准品则有助于识别、定量分析并降低潜在的有害杂质,从而确保最终产品的安全性和有效性。在研发新药或改进现有药物的过程中,正确使用这些标准品可以有效提高产品质量和安全性评估水平。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | didemnin B | 77327-05-0 | C57H89N7O15 |
|
—— | (5E,9E,13Z)-6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one | 3879-23-0 | C23H38O |
|
—— | calcium D-glucarate | 5793-88-4 | C6H8O8*Ca |
|
—— | 1-[(3R,5S,10S,13S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone | 38398-32-2 | C22H36O2 |
|
—— | 2-Dodecyl-3-hydroxy-1,4-naphthoquinone | 57960-31-3 | C22H30O3 |
|
—— | Erythromycin B | 527-75-3 | C37H67NO12 |
|
—— | 5-chlorofuran-2-carbonyl chloride | 24078-79-3 | C5H2Cl2O2 |
|
—— | (+)-(L)-2-(N'-cyclohexylidenehydrazino)-3-(3,4-dihydroxyphenyl)-2-methyl propionic acid methyl ester | 934371-48-9 | C17H24N2O4 |
|
—— | N<sup>1</sup>-methyl-N<sup>1</sup>-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1,3-propanediamine hydrochloride | 81403-69-2 | C14H21N5O2*ClH |
|
—— | (2S,3S,5S)-2-hexyl-3,5-dihydroxyhexadecanoic acid | 130793-30-5 | C22H44O4 |
|
—— | 4-(4-acetoxy-3-methoxybenzylidene)-2-phenyl-5-oxazolone | 18692-68-7 | C19H15NO5 |
|
—— | 4-amino-1-(2-deoxy-α-D-erythropentofuranosyl)-1,3,5-triazin-2(1H)-one | 22432-95-7 | C8H12N4O4 |
|
—— | 4-Ethoxy-3-(pyrid-4-yl)but-3-en-2-on | 88349-61-5 | C11H13NO2 |
|
—— | 6-amino-1,5-dimethylpyrimidine-2,4-(1H,3H)-dione | 63959-47-7 | C6H9N3O2 |
|
—— | 2-methyl-4-(2-methylbenzoylamino)benzoyl chloride | 331947-69-4 | C16H14ClNO2 |
|
—— | 4-amino-(2-methylphenyl)(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]-azepin-1-yl)methanone | 1432725-24-0 | C18H19ClN2O2 |
|
—— | 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenyl 2-methylpropanoate | 895137-81-2 | C26H37NO2 |
|
—— | loperamide oxide | 106900-12-3 | C29H33ClN2O3 |
|
—— | (Z)-11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e] oxepin-2-acetic acid ethyl ester | 113806-03-4 | C23H27NO3 |
|
—— | (R)-α-(cyclopentyl-1-ene)-α-hydroxyl-α-phenylacetic acid | 185030-09-5 | C13H14O3 |
|
—— | desmethylazatadine | 38092-95-4 | C19H20N2 |
|
—— | 4-(E)-4-(dimethylamino)-1-(4-fluorophenyl)but-1-enyl-3-(hydroxymethyl)benzonitrile | 1370643-23-4 | C20H21FN2O |
|
—— | tangshenoside I | 117278-74-7 | C29H42O18 |
|
—— | N-chloroacetyl-L-proline methyl ester | 38074-72-5 | C8H12ClNO3 |
|
—— | (6<i>R</i>)-7<i>t</i>-((<i>R</i>)-2-amino-2-cyclohex-1-enyl-acetylamino)-3-methyl-8-oxo-(6<i>r</i><i>H</i>)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 37051-00-6 | C16H21N3O4S |
|
—— | (6<i>R</i>)-7<i>t</i>-(2-chloro-acetylamino)-3-methyl-8-oxo-(6<i>r</i><i>H</i>)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 40818-86-8 | C10H11ClN2O4S |
|
—— | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide | 917391-28-7 | C12H10F3N3O |
|
—— | (2R,4S)-S-carboxymethylcysteine sulfoxide | 112246-66-9 | C5H9NO5S |
|
—— | (R)-6-{(1R,3aS,7aR)-4-[2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-2-methyl-heptan-2-ol | 140710-90-3 | C33H58O2Si |
|
—— | Tersigat | 30286-75-0 | Br*C19H26NO4 |
|
—— | 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylbenzeneacetic acid hydrochloride | 153439-43-1 | C32H37NO4*ClH |
|
—— | 6-perdeoxy-6-per-chloro gamma-cyclodextrin | 173094-60-5 | C48H72Cl8O32 |
|
—— | ganciclovir dipropionate | 86357-20-2 | C15H21N5O6 |
|
—— | vardenafil monohydrochloride trihydrate | 330808-88-3 | C23H32N6O4S*ClH*3H2O |
|
—— | clarithromycin 9(E)-oxime | 127253-06-9 | C38H70N2O13 |
|
—— | (2S)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogenphosphate salt | 823817-58-9 | C16H15F6N5O*H3O4P |
|
—— | methyl 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetate | 113806-01-2 | C22H25NO3 |
|
—— | ethyl 3-(2-phenylhydrazono)butanoate | 6078-46-2 | C12H16N2O2 |
|
—— | NSC 95097 | 552-72-7 | C22H29NO2 |
|
—— | calcium;(2R,3R,4R,5S,6R)-2,3,4,5,6,7-hexahydroxyheptanoate | 17140-60-2 | C14H26CaO16 |
|
—— | trans-(1R,2R)-diaminocyclohexane platinum dinitrate | 66900-68-3 | C6H14N4O6Pt |
|
—— | Clindamycin sulfoxide | 22431-46-5 | C18H33ClN2O6S |
|
—— | benzilidenerhodanine-N-acetic acid | 82159-06-6 | C12H9NO3S2 |
|
—— | ethyl 4-(8-Chloro-6,11-Dihydro-5H-Benzo[5,6]Cyclohepta(1,2-b]Pyridin-11-Yl)-1-Piperidine-Carboxylate | 167891-69-2 | C22H25ClN2O2 |
|
—— | 4-deacetylvincristine | 3704-01-6 | C44H54N4O9 |
|
—— | 7β-<(E)-2-(2-amino-4-thiazolyl)-2-carboxymethoxyiminoacetamido>-3-vinyl-3-cephem-4-carboxylic acid | 79350-37-1 | C16H15N5O7S2 |
|
—— | FK027 | 79350-37-1 | C16H15N5O7S2 |
|
—— | Benzol-anti-diazohydroxyd | 36966-84-4 | C6H6N2O |
|
—— | (+/-)-N-formylpenicillamine | 158411-82-6 | C6H11NO3S |
|
—— | ethyl 2,3-dioxobutanoate 2-(4-hydroxyphenyl)hydrazone | 132577-23-2 | C12H14N2O4 |
|